Date: Friday March 18, 2016
Time: 12:00 PM until AM
Location: Battle Building, Quayle Learning Center
VEGF Signaling, Anti-Cancer Drugs and Hypertension
Professor Rhian M Touyz MBBCh, PhD, FRCP, FRSE
British Heart Foundation Chair of Cardiovascular Medicine
Director – Institute of Cardiovascular & Medical Sciences
BHF Glasgow Cardiovascular Research Centre
- Cardiovascular effects of modern anti-cancer agents.
- VEGF inhibitors (VEGFI) and the relationship to hypertension.
- VEGF and tyrosine kinase signaling and vascular function
- Potential molecular and vascular mechanisms underlying VEGFI-induced hypertension
*lunch available at 11:30 – please RSVP: Wendy Cline – email@example.com*
Contact firstname.lastname@example.org for more information